Literature DB >> 31801050

Non-alcoholic fatty liver disease, a new and growing risk indicator for cardiovascular disease.

Arne Janssen1, Diederick E Grobbee2, Paul Dendale3.   

Abstract

Entities:  

Year:  2019        PMID： 31801050     DOI： 10.1177/2047487319891783

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  4 in total

Review 1.  Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis.

Authors:  Marija Branković; Igor Jovanović; Marija Dukić; Tijana Radonjić; Svetlana Oprić; Slobodan Klašnja; Marija Zdravković
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  A Pyridazinone Compound for Effectively Treating Non-alcoholic Steatohepatitis by Targeting THRβ.

Authors:  Hao Cheng; Xiao-Bo Wang; Ying Zhi; Bo Liu; Na Liu; Meng-Jun Li; Yan-Ling Mu
Journal:  Front Chem       Date:  2022-05-10       Impact factor: 5.545

3.  The Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Association with Physical Function and Prognosis in Patients with Acute Coronary Syndrome.

Authors:  Takumi Noda; Kentaro Kamiya; Nobuaki Hamazaki; Kohei Nozaki; Takafumi Ichikawa; Masashi Yamashita; Shota Uchida; Emi Maekawa; Tasuku Terada; Jennifer L Reed; Minako Yamaoka-Tojo; Atsuhiko Matsunaga; Junya Ako
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

Review 4.  NAFLD and cardiovascular diseases: a clinical review.

Authors:  Philipp Kasper; Anna Martin; Sonja Lang; Fabian Kütting; Tobias Goeser; Münevver Demir; Hans-Michael Steffen
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.